Prognostic value of blood biomarkers in steroid-refractory or steroid-dependent acute graft-versus-host disease: a REACH2 analysis.

MLA

Socié, Gerard, et al. “Prognostic Value of Blood Biomarkers in Steroid-Refractory or Steroid-Dependent Acute Graft-versus-Host Disease: A REACH2 Analysis.” Blood, vol. 141, no. 22, June 2023, pp. 2771–79. EBSCOhost, https://doi.org/10.1182/blood.2022018579.

APA

Socié, G., Niederwieser, D., von Bubnoff, N., Mohty, M., Szer, J., Or, R., Garrett, J., Prahallad, A., Wilke, C., & Zeiser, R. (2023). Prognostic value of blood biomarkers in steroid-refractory or steroid-dependent acute graft-versus-host disease: a REACH2 analysis. Blood, 141(22), 2771–2779. https://doi.org/10.1182/blood.2022018579

Chicago

Socié, Gerard, Dietger Niederwieser, Nikolas von Bubnoff, Mohamad Mohty, Jeff Szer, Reuven Or, James Garrett, Anirudh Prahallad, Celine Wilke, and Robert Zeiser. 2023. “Prognostic Value of Blood Biomarkers in Steroid-Refractory or Steroid-Dependent Acute Graft-versus-Host Disease: A REACH2 Analysis.” Blood 141 (22): 2771–79. doi:10.1182/blood.2022018579.